Active	Status	Sponsor type	Region	Phase	Filter
1 Active 31 Inactive 32 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
TS-134 / Taisho
NCT05401227: Glutamatergic Mechanisms: Aim2	Suspended	1	120	US	Ketamine, Ts-134, Placebo	New York State Psychiatric Institute, National Institute of Mental Health (NIMH)	Healthy	08/25	08/27